-- The stock added 2.6% after beating expectations for the second quarter. The company reported adjusted earnings of 52 cents per share, while analysts polled by Refinitiv expected 22 cents. Revenue came in slightly lower, however, with the company reporting $3.68 billion against a forecast of $3.69 billion.
- Shares of the pharmaceutical company surged nearly 30% in premarket trading after Apellis released a safety update about Syfovre, a drug used to treat a degenerative eye disease. Apellis said that no direct cause has been found between a side effect and a particular filter needle used with Syfovre, but that practitioners should use a different filter needle instead.
Nederland Laatste Nieuws, Nederland Headlines
Similar News:Je kunt ook nieuwsberichten lezen die vergelijkbaar zijn met deze die we uit andere nieuwsbronnen hebben verzameld.
Stocks making the biggest moves midday: Palo Alto Networks, Nvidia, Tesla, Marvell and moreThese are the stocks posting the largest moves in midday trading.
Lees verder »
Foot Locker's stock tumbles 28% as company suspends dividend after swinging to a lossFoot Locker posted a surprise loss for its second quarter, sales that fell short of estimates and cut its guidance.
Lees verder »